Cue Health https://www.cuehealth.com, a healthcare technology company, has been awarded up to $30 million in base funding and options from the Biomedical Advanced Research and Development Authority (BARDA) https://www.phe.gov/about/BARDA/Pages/default.aspx within HHS.
The funding will be used to accelerate the development and regulatory validation of an over-the-counter “Influenza and Multiplex Respiratory Pathogen” diagnostic cartridges. These cartridges are used in the Cue Health Monitoring System.
The Cue Health Monitoring System centers on a connected diagnostic device which enables a range of in-home and in-clinic diagnostics. The system uses a custom designed reader to test clinical samples in a disposable test cartridge and then sends the results to a mobile application. The mobile applications provides access to features including interventional components such as telemedicine consultations and provides prescribing capabilities for physicians.
The Cue Influenza Cartridge will be focused on detecting Influenza A and B. The Cue Multiplex Respiratory Pathogen Cartridge will be a multiplex assay capable of detecting and differentiating between multiple respiratory pathogens.